|
FOLD
|
Amicus Therapeutics, Inc.
|
0.30%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.30%
|
US
|
NASDAQ
|
|
LEGN
|
Legend Biotech Corporation
|
0.29%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
0.28%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.27%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.26%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.26%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.26%
|
US
|
NASDAQ
|
|
ABCL
|
AbCellera Biologics Inc.
|
0.26%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.24%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.22%
|
US
|
NASDAQ
|